Peralta, Erlinda M.
HRN: 01-07-06 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
CEFTRIAXONE 1G (VIAL)
04/10/2025
04/17/2025
IV
2g
OD
CAP-MR
Waiting Final Action